KINTARA THERAPEUTICS
Kintara Pharmaceuticals, Inc. engages in developing and commercializing cancer therapies in orphan and other cancer indications for the treatment of patients failing modern targeted or biologic therapy. The company’s principal product candidate includes VAL-083, a small-molecule chemotherapeutic agent, which is in clinical trials stage for the treatment of refractory glioblastoma multiforme, a form of brain cancer. Kintara Pharmaceuticals, Inc. also has a strategic collaboration with Guangxi Wuzhou Pharmaceutical Company for the development of VAL-083 used in treating chronic myelogenous leukemia and lung cancer. The company was founded in 2010 and is headquartered in Vancouver, Canada.
KINTARA THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2010-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.kintara.com
Total Employee:
1+
Status:
Active
Contact:
604-629-5989
Email Addresses:
[email protected]
Total Funding:
105.83 M USD
Technology used in webpage:
SPF Amazon Google Apps For Business Cloudflare DNS Amazon Virginia Region Pound Sterling Japanese Yen Amazon Singapore Region Amazon Sydney Region
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-06-10 | Adgero Biopharmaceuticals | Adgero Biopharmaceuticals acquired by Kintara Therapeutics | N/A |
Investors List
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - Kintara Therapeutics
Luxembourg National Research Fund
Luxembourg National Research Fund investment in Grant - Kintara Therapeutics
SternAegis
SternAegis investment in Post-IPO Equity - Kintara Therapeutics
Official Site Inspections
http://www.kintara.com Semrush global rank: 6.44 M Semrush visits lastest month: 1.01 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Kintara Therapeutics"
Management Team :: Kintara Therapeutics, Inc. (KTRA)
Mr. Hoffman formerly served as a director and President of the San Diego Chapter of Financial Executives International and was an advisor to the Financial Accounting Standard Board …See details»
Corporate Governance :: Kintara Therapeutics, Inc. (KTRA)
In 2008 and 2010, she was honored as a biotechnology entrepreneur by the national organization, Women in Bio, and in 2008 received the Rising Star Award by the Wisconsin Biotech and …See details»
Investors :: Kintara Therapeutics, Inc. (KTRA)
Oct 14, 2024 Kintara Therapeutics, Inc. 9920 Pacific Heights Blvd, Suite 150 San Diego, CA 92121 United States T: 858-350-4364 [email protected]. Investor Relations. T: 858-350-4364 [email protected]. Transfer Agent. Mountain Share …See details»
Kintara Therapeutics - Crunchbase Company Profile
Kintara Pharmaceuticals, Inc. engages in developing and commercializing cancer therapies in orphan and other cancer indications for the treatment of patients failing modern targeted or biologic therapy. The company’s principal product …See details»
kintara.com - Whois.com
Feb 18, 2015 Domain Name: KINTARA.COM Registry Domain ID: 1903896884_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.NameBright.com …See details»
Kintara Therapeutics, Inc. Company Profile | San Diego, CA ...
Find company research, competitor information, contact details & financial data for Kintara Therapeutics, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Kintara Therapeutics Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Kintara Therapeutics Inc of Vancouver, BC. Get the latest business insights from Dun & Bradstreet.See details»
About :: Kintara Therapeutics, Inc. (KTRA)
Kintara Therapeutics has teamed up with outstanding academic and clinical research institutions from around the world to support the development of our novel cancer therapies. Our Mission & Values Guiding Principles for All of Our …See details»
Kintara Therapeutics Company Profile 2024: Valuation, Investors ...
Kintara Therapeutics General Information Description. Provider of cancer therapies intended to treat common and aggressive forms of cancer in the human body. The company's platform …See details»
Kintara Therapeutics Provides Update on Corporate Developments …
Sep 11, 2024 Kintara's existing stockholders will own approximately 5.45% of combined company's common stock at the closing of the proposed Merger on a pro forma fully diluted …See details»
Kintara Therapeutics - Craft
Oct 17, 2024 Kintara Therapeutics has 5 employees across 3 locations. See insights on Kintara Therapeutics including office locations, competitors, revenue, financials, executives, …See details»
Kintara Therapeutics - BIO International Convention | BIO
Jun 7, 2023 The Biotechnology Innovation Organization is the world's largest biotech trade association. Learn about BIO, register for events and explore member services. ... Kintara …See details»
Board Committees :: Kintara Therapeutics, Inc. (KTRA)
In 2008 and 2010, she was honored as a biotechnology entrepreneur by the national organization, Women in Bio, and in 2008 received the Rising Star Award by the Wisconsin Biotech and …See details»
Kintara Therapeutics Announces Initiation of REM-001 Clinical Trial …
Feb 12, 2024 Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, …See details»
Kintara Therapeutics Provides Update on Corporate ... - Morningstar
Sep 11, 2024 Information about Kintara's directors and executive officers is available in Kintara's proxy statement, which was filed with the SEC on May 17, 2024 for the 2024 Annual Meeting …See details»
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive ...
Apr 3, 2024 Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara"), a biopharmaceutical company investigating REM-001 in an NIH-sponsored and funded open label study in …See details»
Kintara Therapeutics and TuHURA Biosciences Enter into ... - Nasdaq
Apr 3, 2024 About the Proposed Transaction, Management & Organization. Under the terms of the merger agreement, subject to stockholder approval, on a pro forma basis, post-merger …See details»
Kintara Therapeutics Announces Fiscal 2023 Year Financial Results …
SAN DIEGO, Sept. 18, 2023 /PRNewswire/ -- Kintara Therapeutics, Inc. (NASDAQ: KTRA) ("Kintara" or the "Company"), a biopharmaceutical company focused on the development of …See details»
Board of Directors :: Kintara Therapeutics, Inc. (KTRA)
In addition, Ms. Johnson has served as a member of the board of directors of Harmony Hill Farm Sanctuary since 2019. In 2008 and 2010, she was honored as a biotechnology entrepreneur …See details»